Hello, I'm John Schrom. I'm an epidemiologist and informaticist working on infectious diseases and global health at University of California, San Francisco. I'm always happy to connect via email at john@schrom.org.
Kakande E, Ayieko J, Sunday H, Biira E, Nyabuti M, Agengo G, Kabami J, Aoko C, Athuhaire H, Sang N, Owaranganise A, Litunya J, Mugoma E, Chamie G, Peng J, Schrom J, Bacon M, Kamya M, Havlir D, Petersen M, Balzer L. A community-based dynamic choice model for HIV prevention improves PrEP and PEP coverage in rural Uganda and Kenya: a cluster randomized trial. J International AIDS Society.
Puryear S, Mwangwa F, Opel F, Chamiel G, Balzer L, Kabami J, Ayieko J, Owaraganise A, Kakande E, Agengo G, Bukusi E, Kabagen S, Omoding D, Bacon M, Schrom J, Woolf-King S, Petersen M, Havlir D, Kamya M, Hahn J. Effect of a brief alcohol counselling intervention on HIV viral suppression and alcohol use among persons with HIV and unhealthy alcohol use in Uganda and Kenya: a randomized controlled trial. J International AIDS Society.
Ruel T, Mwangwa F, Balzer L, Ayieko J, Nyabuti M, Mugoma W, Kabami J, Kamugisha B, Black D, Nzarubara B, Opel F, Schrom J, Ageengo G, Nakigudde J, Atuhaire H, Schwab J, Peng J, Camlin C, Shade S, Bukusi E, Kapogiannis B, Charlebois E, Kamya M, Havlir D. A multilevel health system intervention for virological suppression in adolescents and young adults living with HIV in rural Kenya and Uganda (SEARCH-Youth): a cluster randomised trial. Lancent HIV.
Schrom J, Marquez C, Wang C, Saxena A, Mitchell A, Ribeiro S, Pilarowski G, Nakamura R, Rojas S, Black D, Contreras Oseguera M, Castellanos Diaz E, Payan J, Rojas S, Jones D, Tulier-Laiwa V, Zavaleta A, Martinez J, Chamie G, Glaser C, Jacobsen K, Petersen M, DeRisi J, Havlir D. Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges. PLOS ONE.
Marquez C, Kerkhoff A, Schrom J, Rojas S, Black D, Mitchell M, Wang C, Pilarowski G, Ribeiro S, Jones D, Payan J, Manganelli S, Rojas S, Lemus J, Jain V, Chamie G, Tulier-Laiwa V, Petersen M, DeRisi J, Havlir D. COVID-19 symptoms and duration of direct antigen test positivity at a community testing and surveillance site, January 2021-2022. JAMA Open.
Kerkhoff A, Rojas S, Black D, Ribeiro S, Rojas S, Valencia R, Lemus J, Payan J, Schrom J, Jones D, Manganelli S, Bandi S, Chamie G, Tulier-Laiwa V, Petersen M, Havlir D, Marquez C. Integrating Rapid Diabetes Screening Into a Latinx Focused Community-Based Low-Barrier COVID-19 Testing Program. JAMA Open.
Acharya C, Schrom J, Mitchell A, Coil D, Marquez C, Rojas S, Wang C, Liu J, Pilarowski G, Solis L, Georgian E, Belafksy S, Petersen M, DeRisi J, Michelmore R, Havlir D. Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected with the SARS-CoV-2 Delta Variant. Open Forum Infectious Diseases.
Schrom J, Marquez C, Pilarowski G, Wang C, Mitchell A, Puccinelli R, Black D, Rojas S, Ribeiro S, Martinez J, Jones D, Nakamura R, Chamie G, Jain V, Petersen M, DeRisi J, Havlir D. Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge. Annals of Internal Medicine.